Frontiers in Hematology

Original Research

Published on 11 Sep 2024

Real-life experience with first-line treatment with daratumumab, bortezomib, melphalan, and prednisone in patients with newly diagnosed multiple myeloma ineligible for autologous stem-cell transplantation

in Blood Cancer

Amalia Domingo-González
Rafael Alonso Fernández
Ana Jiménez
Teresa De Soto Álvarez
Ana Lerma-Verdejo
Virginia Pradillo
Gonzalo Benzo Callejo
Jose Sánchez-Pina
Elena Landete
Alberto Velasco-Valdazo

Frontiers in Hematology

doi 10.3389/frhem.2024.1438233

790 views

Editorial

Published on 29 Aug 2024

Editorial: Rising stars in hematopoiesis and stem cells 2023

in Hematopoiesis and Stem Cells

Marcus O. Muench
Kristbjorn Orri Gudmundsson

Frontiers in Hematology

doi 10.3389/frhem.2024.1477997

666 views

Perspective

Published on 27 Aug 2024

Sickle cell disease: a comparative perspective on global and national initiatives

in Red Cells, Iron and Erythropoiesis

Alok Kumar
Sudip Bhattacharya

Frontiers in Hematology

doi 10.3389/frhem.2024.1457158

4,411 views
2 citations

Editorial

Published on 14 Aug 2024

Editorial: Glycobiology in hematology: a promising avenue for cancer diagnostics and therapeutics

in Blood Cancer

Tao Zhang
Valerie R. Wiersma

Frontiers in Hematology

doi 10.3389/frhem.2024.1465473

837 views

Review

Published on 09 Aug 2024

The nexus between Helicobacter pylori infection and anemia—a systematic review

in Red Cells, Iron and Erythropoiesis

Sankeerth Kumar Motupalli
Terry L. Oroszi

Frontiers in Hematology

doi 10.3389/frhem.2024.1423494

3,473 views
1 citation

Review

Published on 06 Aug 2024

Are we ready to integrate 3D culture systems in acute myeloid leukemia and bone marrow microenvironment research?

in Hematopoiesis and Stem Cells

Azmeer Sharipol
Benjamin J. Frisch

Frontiers in Hematology

doi 10.3389/frhem.2024.1407698

2,823 views
2 citations

Community Case Study

Published on 25 Jul 2024

Effectiveness of biosimilar pegfilgrastim in patients with lymphoma after high-dose chemotherapy and autologous stem cell transplantation: a real-life study

in Blood Cancer

Barbara Loteta
Annalisa Pitino
Martina Pitea
Caterina Alati
Giovanni Tripepi
Maria Caterina Mico'
Maria Pellicano'
Francesca Cogliandro
Gaetana Porto
Giorgia Policastro

Frontiers in Hematology

doi 10.3389/frhem.2024.1441070

855 views

Mini Review

Published on 22 Jul 2024

Targeting the bone marrow niche, moving towards leukemia eradication

in Blood Cancer

Carla Semedo
Raquel Caroço
António Almeida
Bruno António Cardoso

Frontiers in Hematology

doi 10.3389/frhem.2024.1429916

1,853 views

Original Research

Published on 15 Jul 2024

Real-world analysis of the underdiagnosis, clinical outcomes and associated burden of hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) in the United States

in Hematopoiesis and Stem Cells

Yan Wang
Andrew Rava
Marlene Smurzynski
Bonny Shah
Anusorn Thanataveerat
Imad Al-Dakkak
Moh-Lim Ong
Christopher C. Dvorak
Vincent T. Ho

Frontiers in Hematology

doi 10.3389/frhem.2024.1405311

3,608 views

Review

Published on 12 Jul 2024

Clonal cytopenia of undetermined significance: definitions, risk and therapeutic targets

in Blood Cancer

Cristian C. Taborda
Amer M. Zeidan
Lourdes M. Mendez

Frontiers in Hematology

doi 10.3389/frhem.2024.1419323

3,426 views
1 citation

Case Report

Published on 10 Jul 2024

Case report: Aggressive natural killer cell leukemia and refractory hemophagocytic lymphohistiocytosis in an adolescent

in Blood Cancer

Caroline Spaner
Jessica Durkee-Shock
Andrew Weng
Ryan Stubbins
Alina S. Gerrie
Stefania Pittaluga
Jeffrey I. Cohen
Luke Y. C. Chen

Frontiers in Hematology

doi 10.3389/frhem.2024.1413794

1,161 views

Review

Published on 08 Jul 2024

The sweet symphony of N-glycans in myeloid malignancies

in Blood Cancer

Javier Sanmartín-Martínez
Valerie R. Wiersma
Anna E. Marneth

Frontiers in Hematology

doi 10.3389/frhem.2024.1415618

1,006 views
1 citation

Mini Review

Published on 05 Jul 2024

Congenital dyserythropoietic anemia type II and ineffective erythropoiesis: challenges in diagnosis and management

in Red Cells, Iron and Erythropoiesis

Imo J. Akpan
Kelsie Bogyo
Rebecca J. Leeman-Neill
Julia Wattacheril
Richard O. Francis

Frontiers in Hematology

doi 10.3389/frhem.2024.1389820

1,814 views
1 citation

Original Research

Published on 20 Jun 2024

Effectiveness, safety, and tolerability of delayed dexamethasone, rituximab, and cyclophosphamide as first-line treatment in patients with Waldenström macroglobulinemia: data from the Sicilian Myeloma Network

in Blood Cancer

Vittorio Del Fabro
Uros Markovic
Sara Frazzetto
Roberta Sciortino
Claudia Bellofiore
Mary Ann Di Giorgio
Valerio Leotta
Anna Bulla
Angelo Curto Pelle
Federica Elia

Frontiers in Hematology

doi 10.3389/frhem.2024.1425677

860 views

Brief Research Report

Published on 17 Jun 2024

Novel cryopreservation medium for enhanced stability of T cells at −80°C

in Immunobiology and Immunotherapy

WenXuan Zhou
Chen Wang
Yao Shi
Yi Pan
XiaDuo Meng
XunLei Kang
Xu Han

Frontiers in Hematology

doi 10.3389/frhem.2024.1346627

2,119 views
2 citations

Brief Research Report

Published on 13 Jun 2024

First clinical experience of isatuximab safety and tolerability in relapsed and refractory multiple myeloma: real-world data from a compassionate use program in Germany

in Blood Cancer

Theo Leitner
Cyrus Khandanpour
Knut Wendelin
Fuat Oduncu
Christoph Kimmich
Ralph Naumann
Miriam Kull
Hartmut Goldschmidt
Martin Ehmer
Claudia Kiewitz

Frontiers in Hematology

doi 10.3389/frhem.2024.1335161

923 views